baber/WOPTO huggingface dataset:
Patent AU-2014202969-A1 (AU)
Title: Access alarm
Inventor: SMITH DENNIS
IPC: G08B21/02
Filed: 2014-06-02
Abstract: ACCESS ALARM 5 An alarm system comprises a tripwire having at least one end attached to a detection assembly comprising an elongate shank, a housing supporting the elongate shank, a coil spring mounted on the shank which provides a restoring force to movement of the shank outwardly from the housing, a micro switch operatively associated with the shank and an alarm electrically connected to 10 the micro switch such that tripping of the wire activates the alarm. 4 8 61- 59 60- 53 -48 64 T ------L1 24--- F IG 8A 63)7 70 62 69 48 I63, 24 6171 66 2 18-- - -2 -24 FIG 10
Patent AU-2014203779-A1 (AU)
Title: Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
Inventor: MAO WEIGUANG
IPC: C07K16/28
Filed: 2014-07-10
Abstract: Cysteine engineered anti-TENB2 antibodies are engineered by replacing one or more amino acids of a parent anti-TENB2 antibody with non cross-linked, reactive cysteine 5 amino acids. Methods of design, preparation, screening, and selection of the cysteine engineered anti-TENB2 antibodies are provided. Cysteine engineered anti-TENB2 antibodies (Ab) are conjugated with one or more drug moieties (D) through a linker (L) to form cysteine engineered anti-TENB2 antibody-drug conjugates having Formula 1: Ab-(L-D)p I 10 where p is 1 to 4. Diagnostic and therapeutic uses for cysteine engineered antibody drug compounds and compositions are disclosed. 5553774_1 (GHMatters) P83470.AU.1
Patent AU-2014216039-A1 (AU)
Title: Composition, System and Method for Treating an Exhaust Gas
Inventor: MCLEAN BRIAN JAMES
IPC: B01D53/92
Filed: 2014-08-24
Abstract: -31 Abstract A composition including a first part which is combinable with a second part for the treatment of exhaust in a scrubber box, the first part including a surfactant, a solvent and an alkali and the second part including a defoaming agent. In some examples, the first part further includes an emulsifying surfactant and water. The first part may include from about 1 part to 20 parts of the surfactant, about 1 part to 30 parts of the emulsifying surfactant, about 1 part to 20 parts of the solvent and about 1 part to 15 parts of the alkali with the balance being the water to create a total of about 100 parts. The defoaming agent of the second part may include at least one of an oil, a silicone defoamer, an ethylene oxide compound and a propylene oxide compound and in some examples the silicone defoamer is a silicone emulsion. There is also disclosed a method of treatment of an exhaust gas utilising the composition as well as a system for combining the first part and the second part so as to form a treatment chemical for use within an exhaust treatment apparatus to treat the exhaust gas. Dosing Dosing Pressure FiIe Device A Device B Regulator Fle Pressurised Water Source Composition Composition Part A Part B Treatment Composition Header Tank Scrubber Box Figure 1
Patent AU-2014233574-A1 (AU)
Title: A device implantable under skin
Inventor: BENDSEN HENRIK
IPC: A61N1/375
Filed: 2014-09-24
Abstract: A device implantable under skin includes a sealed housing containing electronics for at least stimulation or collection of data and at least one antenna for communicating with an external device and a magnet configured to hold the external device in proximity to the sealed housing. The sealed housing includes an upper cover being closest to the skin when the device is implanted, and a lower cover that is hermetically connected to the upper cover. The lower cover includes an elevated region, a recessed region, and at least one feedthrough element formed in the recessed region of the lower cover. The recessed region provides space for a lead to connect to the feedthrough element and protects it from shock and other environmental risks.
Patent AU-2014236729-A1 (AU)
Title: Systems, devices, and method for treating a sinus condition
Inventor: ABBATE ANTHONY J
IPC: A61M29/02
Filed: 2014-03-13
Abstract: Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration In some instances a delivery device may aid in crimping and/or delivery of the implant.
Patent AU-2014243795-A1 (AU)
Title: Treated metathesis substrate materials and methods of making and using the same
Inventor: WAMPLER KEITH M
IPC: C07C6/02
Filed: 2014-03-13
Abstract: A method for treating a substrate prior to a metathesis reaction includes treating the substrate with a first agent configured to mitigate potentially adverse effects of one or more contaminants in the substrate on a catalyst used to catalyze the metathesis reaction. The treating reduces a level of the one or more contaminants by an amount sufficient to enable the metathesis reaction to proceed at a substrate-to-catalyst molar ratio of at least about 7,500 to 1. Methods for metathesizing substrates are described.
Patent AU-2014246622-A1 (AU)
Title: foot and ankle scanner
Inventor: HERREEN JONATHAN
IPC: A43D1/02
Filed: 2014-10-10
Abstract: Abstract - Foot scanning device A method for the production of customised footwear by obtaining an accurate model of a patient's foot using a three dimensional scanner controlled by a controlling computer device. This model can then be communicated by sending via the internet to a server where it's combined with a footwear design database to produce a customized footwear design, which is communicated over the internet to a three dimensional printer. This technique can be used to manufacture orthopaedic footwear. The equipment may be located all at the same or at separate locations. - -- - --- -- - Figure 1
Patent AU-2014252717-A1 (AU)
Title: Pharmaceutical compositions comprising kisspeptin or derivatives thereof
Inventor: NETO DOLIVAR CORAUCCI
IPC: A61K9/22
Filed: 2014-04-09
Abstract: The present invention relates to pharmaceutical compositions comprising a peptide that stimulates the release of gonadotropins and sexual steroids. More specifically, the present invention proposes pharmaceutical compositions comprising kisspeptin, preferably in the kp-10 form, or derivatives thereof, for use in ovulation cycle inducing and/or infertility treatment programs. The formulations according to the present invention belong to two main groups: injectable solutions and implantable formulations. The injectable solutions according to the present invention can be divided into immediate release solutions and prolonged action solutions. The implantable formulations according to the present invention can be prepared using an RTV silicone elastomer, a rapid vulcanisation silicone elastomer or a rapid vulcanisation silicone elastomer with a release modulator.
Patent AU-2014257156-A1 (AU)
Title: Seal compatibility additive to improve fluoropolymer seal compatibility of lubricant compositions
Inventor: DESANTIS KEVIN
IPC: C10M169/04
Filed: 2014-04-22
Abstract: This disclosure is directed to an additive package for a lubricant composition that provides improved compatibility with fluoropolymer seals. The additive package comprises a seal compatibility additive. The disclosure is also directed to a lubricant composition comprising a base oil and a seal compatibility additive. The seal compatibility additive improves the compatibility with fluoropolymer seals of the resultant lubricant composition.
Patent AU-2014260529-A1 (AU)
Title: A rotor assembly for an open cycle engine, and an open cycle engine
Inventor: LYNN ROBERT GULLIVER
IPC: F02C5/04
Filed: 2014-04-29
Abstract: A rotor assembly for an engine, comprising: a rotor, supported on bearings for axial rotation, a rotor portion forming a compression passage extending outwards from the axis, gases entering the rotor through inlets at the axis and flowing outwards through the compression passage; a combustion chamber supported within the compression passage near the maximum radius of the rotor having a closed outer end and combustion chamber gases inlets through which gases enter the combustion chamber, each combustion chamber having a fuel inlet, and; one or more expansion passages in fluidic connection with and extending radially inwards from the combustion chamber within a compression passage and fluidically connecting at or near the rotor axis to a combustion gas outlet tube that extends along the rotor axis, combustion gases created by combustion of fuel with inlet gases within the combustion chamber expanding as they flow inwards through the expansion passage.
Patent AU-2014265094-A1 (AU)
Title: Ophthalmic lens with retinal vascularization monitoring system
Inventor: PUGH RANDALL BRAXTON
IPC: A61B8/02
Filed: 2014-11-21
Abstract: The present invention relates to an ophthalmic device with a retinal vascularization monitoring system and associated methods. In some embodiments, the ophthalmic device can be a contact lens with a retinal vascularization monitoring system that can be used to monitor temporal changes of a pulsating vessel forming part of the retinal vascularization. Further, the retinal vascularization monitoring system may include elements for delivering a signal, including an audible and/or visual message, to the user that can be useful for identifying abnormal conditions such as a cardiac failure without delay. The audible and/or visual messages can be signals communicated to the user using one or both of the ophthalmic device and a wireless device in communication with the ophthalmic device. Fig._1B 1of8
Patent AU-2014265934-A1 (AU)
Title: A thermally-activated gellant for an oil or gas treatment
Inventor: MILLER MATTHEW L
IPC: C09K8/035
Filed: 2014-02-17
Abstract: A treatment fluid for treating a portion of a subterranean formation comprises: a base fluid, wherein the base fluid comprises a hydrocarbon liquid; and a gellant, wherein the gellant: is a polymer; and is activated at an activation temperature, wherein the thermal activation of the gellant causes the treatment fluid to become a gel. A method of treating a portion of a subterranean formation includes introducing the treatment fluid into the portion of the subterranean formation, wherein the subterranean formation is penetrated by a well, wherein at least a portion of the well has a bottomhole temperature greater than or equal to the activation temperature, and wherein the step of introducing comprises introducing the treatment fluid into the portion of the well.
Patent AU-2014270701-A1 (AU)
Title: Cassette for receiving an intraocular lens, injector device having a cassette and method for folding an intracular lens into a cassette
Inventor: RAQUIN VINCENT
IPC: A61F2/16
Filed: 2014-04-10
Abstract: The invention relates to a cassette (6) for housing an intraocular lens (14), which comprises a base part (36) on which pivotable cover flaps (19, 20) are arranged with respect to the base part (36) about the longitudinal axis (A) of the cassette (6). Said cover flaps (19, 20) are curved at least in sections, in particular in the base position of arc-shaped flap sections (42, 47) and can fold into themselves in a defined and autonomous manner (when closing), when closing the cover flaps (19, 20). The invention also relates to an injector device (1) for introducing an intraocular lens (14) into an eye, comprising a cassette (6). The invention also relates to a method for pre-folding an intraocular lens (14) in a cassette (6).
Patent AU-2014271336-A1 (AU)
Title: Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof
Inventor: LAI YU-CHIN
IPC: G02C7/04
Filed: 2014-12-05
Abstract: The present disclosure provides a UV-blocking silicone hydrogel composition including a hydrophilic silicone macromer, a UV-blocking monomer, a first hydrophilic monomer, a crosslinker and a polymerization initiator. The hydrophilic silicone macromer has a general formula: V-L-S-(L'-V')x, wherein V and V' are independently ethylenically-based polymerizable groups, L and L' are independently a covalent bond or a linkage group, S is a siloxane group having a chemical structure such as R2 -- R1O1 or * Si Si -Si, S I I 'R1 [R 1 J L R1 R1 R2 -O O R2 -, and x is 0 or 1. A silicone contact lens 1- 2 1 1 0. 'R1SI' Si' SK. II I R, R1 - R, R1 containing the UV-blocking silicone hydrogel composition is also provided herein.
Patent AU-2014272776-A1 (AU)
Title: Pyrazolopyrrolidine derivatives and their use in the treatment of disease
Inventor: BLANK JUTTA
IPC: C07D487/04
Filed: 2014-05-26
Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Patent AU-2014277971-A1 (AU)
Title: Surgical suit
Inventor: GIULIANOTTI PIER
IPC: A41D13/12
Filed: 2014-06-13
Abstract: A body surgical suit to be worn by surgery patients during surgical procedures, said body surgical suit being configured to encase the limbs and torso of a patient is described. The body surgical suit has one or more openings allowing to access one or more portions of the body of a patient wearing the body surgical suit, one or more sensors configured to monitor the patient's vital signs, a control monitor configured to control operation of the sensors, and selectively operatable contractive elements arranged in the legs and/or arms portions and configured to allow peristaltic movement of blood in the arms and legs of a patient wearing the body surgical suit.
Patent AU-2014284234-A1 (AU)
Title: Methods and characteristics for the diagnosis of acute lymphoblastic leukemia
Inventor: OFFIT KENNETH
IPC: C12Q1/68
Filed: 2014-06-20
Abstract: Methods for identification of leukemia or a genetic predisposition to leukemia are provided that are particularly applicable to acute lymphoblastic leukemia (ALL). A novel heterozygous germline variant, c.547G>A (p.Gly183Ser) in the octapeptide domain of PAX5, is used to identify those individuals with an enhanced risk or predisposition to ALL.
Patent AU-2014300266-A1 (AU)
Title: Heat transfer tube expansion apparatus and heat transfer tube expansion method
Inventor: TANAKA YOSHIKAZU
IPC: F28F1/32
Filed: 2014-05-01
Abstract: A heat transfer pipe affixing device (103) for a heat transfer pipe expanding device (1) is provided with a gripping section (37a) and a movable section (32). The gripping section (37a) grasps one axial end (203a) of a heat transfer pipe (203) which has been inserted through heat transfer fins (202). The movable section (32) is moved in the axial direction of the heat transfer pipe (203) and thereby switched between a first state in which the movable section (32) covers around the gripping section (37a) and a second state in which the movable section (32) does not cover around the gripping section (37a). Expanding the heat transfer pipe (203) while the movable section (32) is in the first state causes the gripping section (37a) to affix the heat transfer pipe (203) so that the heat transfer pipe (203) does not axially move and affixes the heat transfer fins (202) and the heat transfer pipe (203) together.
Patent AU-2014303085-A1 (AU)
Title: Process for producing dark brown natural cocoa
Inventor: DE MUIJNCK LEANNE
IPC: A23G1/56
Filed: 2014-06-04
Abstract: Natural, dark brown cocoa products are disclosed. Processes for producing such natural, dark brown cocoa products are also disclosed, as well as foods including such cocoa products. In each of various embodiments, the present invention helps fulfill these needs and discloses processes for producing "natural" cocoa products that have the color of alkalized cocoa products. Cocoa products produced by such methods are also disclosed.
Patent AU-2014303405-A1 (AU)
Title: Sheet Product Wrapping Apparatus
Inventor: TOTANI MIKIO
IPC: B65B35/36
Filed: 2014-08-07
Abstract: Stacked sheet-like products (1) are clamped by a clamp lever (3) at a position close to one end of the sheet-like products (1). In addition, the clamp lever (3) rotates at the angle of 180 degrees, and the sheet-like products (1) are turned upside down by the clamp lever (3). In addition, the sheet-like products (1) are received and held by a horizontal member (13), and a press bar (14) is pressed against the sheet-like products (1) and moved along the sheet-like products (1) so that the sheet-like products (1) are flattened out by the press bar (14). Subsequently, the sheet-like products (1) are packaged with a packaging material (17).
Patent AU-2014309113-A1 (AU)
Title: Cleated footwear with flexible cleats
Inventor: HATFIELD TOBIE D
IPC: A43C15/16
Filed: 2014-08-18
Abstract: Flexible cleats for flexible footwear (e.g., with natural motion sole structures) include a cleat structure that generally has the appearance of a cleat that has been separated into individual component parts by one or more flex grooves formed into the sole structure. Such structures provide additional flexibility at the areas of the cleats so as to avoid a stiff feeling in certain areas and/or during certain activities. The flexible cleats may be arranged around one or more intersections of flex grooves provided in a sole member, optionally in the form of an array of sole pods provided at least in a forefoot area of the sole member.
Patent AU-2014309637-A1 (AU)
Title: Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating rheumatoid arthritis
Inventor: KIM JAE WHA
IPC: A61P19/02
Filed: 2014-08-18
Abstract: The present invention relates to a pharmaceutical composition for preventing, treating, or alleviating rheumatoid arthritis, a composition for a functional health food, and a medicinal compound. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting phosphorylation of STAT-3, which is known as a target material in treating rheumatoid arthritis, and thus can overcome side effects of currently used therapeutic agents for rheumatoid arthritis. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, and alleviating rheumatoid arthritis.
Patent AU-2014353344-A1 (AU)
Title: Apparatus and method for enabling roaming radios to operate in different systems during an incident event
Inventor: OO MYO TUN
IPC: H04W4/90
Filed: 2014-11-10
Abstract: A controller in a network assigns (402) a dedicated foreign radio talk group to each radio frequency RF site in the network for use by foreign radios during an incident event. The controller receives (404) a registration request from a foreign radio and registers the foreign radio in a first RF site. The controller receives a talk group affiliation request from the foreign radio and, responsive to determining (406) that the first RF site is in the incident event mode, affiliates (412) the foreign radio with dedicated foreign radio talk group that is assigned to the first RF site, associated with at least one of a system identifier, a Wide Area Communication Network identifier and a talk group identifier provided by the foreign radio, and/or associated with the talk group identifier provided by the foreign radio and included in a master list including talk group IDs associated with a function.
Patent AU-2014370511-A1 (AU)
Title: Asbestos processing
Inventor: JANSEN KLAAS
IPC: F23G5/00
Filed: 2014-12-23
Abstract: The invention is directed to a method for processing asbestos-containing steel scrap into useful products, which products can be handled in a safe manner. In accordance with the present invention the asbestos-containing steel scrap is melted in a furnace, which results in destruction of the asbestos fibers. It has been found possible to carry out such a process in an economically feasible manner. In accordance with the invention asbestos-containing steel is heated to high temperature so that the steel melts. As a result the asbestos will be converted into harmless material, which allows for safe handling and processing of the resulting products.
Patent AU-2014370697-A1 (AU)
Title: Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
Inventor: YOO SANG KU
IPC: A61K31/353
Filed: 2014-12-23
Abstract: Provided are a pyranochromenyl phenol derivative, a pharmaceutically acceptable salt thereof, or a solvate thereof. Also provided is a pharmaceutical composition for preventing or treating metabolic syndrome or inflammatory disease comprising same. The present invention is efficacious in preventing or treating metabolic syndrome or inflammatory disease and is chemically stable.
Patent AU-2014377017-A1 (AU)
Title: Storage device for tools
Inventor: ABEL MICHAEL
IPC: B25H3/02
Filed: 2014-12-19
Abstract: The invention relates to a device for storing tools, in particular screwdriving tools, having a planar main body (1) which has an inner side (2) and an outer side (3), wherein holding devices (4, 6, 8, 10, 12) for retaining the tools (5, 7, 9, 11, 13) on the main body (1) are provided on the inner side (2), wherein the main body (1) is divided up into surface portions (18, 19, 20, 21, 22) by a number of hinges (14, 15, 16, 17), said surface portions (18, 19, 20, 21, 22) being foldable about the hinges (14, 15, 16, 17) from a tool-removal position, in which the surface portions (18, 19, 20, 21, 22) are located substantially in one plane, into a storage position, in which the outer sides (3) of the surface portions (18, 19, 20, 21, 22) form planar surfaces of a polygonal solid body.
Patent AU-2014380388-A1 (AU)
Title: Systems and methods for interrelated control of chlorinators and pumps
Inventor: MURDOCK JAMES
IPC: C02F1/467
Filed: 2014-01-28
Abstract: Systems and methods for combined controlling chlorinators and pumps for pools and spas are provided. Exemplary embodiments can include a pump operable to circulate a fluid for a specified time period according to a pump operation time setting and a chlorinator operatively coupled to the pump. The chlorinator can be configured to generate chlorine based on a chlorine output setting, a chlorine generation capacity of the chlorinator, and the pump operation time. A controller can be operatively coupled to the chlorinator and the pump and can be programmed to control the chlorinator and the pump based on a relationship between the chlorine output setting, a chlorine generation capacity of the chlorinator, and the pump operation time.
Patent AU-2014395086-A1 (AU)
Title: Composition of a degradable diverting agent and a degradable accelerator with tunable degradable rate
Inventor: REDDY B RAGHAVA
IPC: C09K8/035
Filed: 2014-05-22
Abstract: Methods and compositions for a treatment fluid composition are disclosed for use within a subterranean formation, comprising: a degradable diverting agent, and a Schiff base comprising a degradation accelerator. The treatment fluid may be introduced into a formation and the Schiff base allowed to hydrolytically release the degradation accelerator, allowing the degradation accelerator to degrade the degradable diverting agent.
Patent WO-2015120514-A1 (WO)
Inventor: ARDAGH MARTIN WILLIAM IRVINE
IPC: E04G21/18
Filed: 2015-02-09
Abstract: L'invention concerne un profilé (10) pour construire un mur de briques (12), le profilé (10) comprenant une première section de profilé (14) couplée à une seconde section de profilé (16) de manière à être mobile de façon télescopique entre une position étendue et une position rétractée, le premier profilé (14) comprenant une première surface de butée (22) et la seconde section de profilé (16) comprenant une seconde surface de butée (24), les première et seconde surfaces de butée (22, 24) étant alignées l'une avec l'autre, permettant ainsi la construction d'une section droite du mur de briques (12) entre elles.